Percutaneous closure of the small (&lt; 2.5 mm) patent ductus arteriosus using coil embolization

Cambier, Patrick A.; Kirby, William C.; Wortham, Dale C.; Moore, John W.

doi:10.1016/0002-9149(92)90514-y

Cited by 288 publications

(159 citation statements)

References 8 publications

Supporting

Mentioning

144

Contrasting

Unclassified

Order By: Relevance

“…Results with the use of the Gianturco coil were first reported by Cambier et al in 1992. 8 Shim et al described a 20-month completeocclusion rate of 94% with this coil. 9 However, if the Gianturco coil is extruded, it cannot be retrieved without other instruments (eg, snares).…”

Section: Discussionmentioning

confidence: 92%

Transcatheter Coil Embolization of Large-Size Patent Ductus Arteriosus in Adult Patients

et al. 1999

View full text Add to dashboard Cite

ranscatheter occlusion of a small ductus arteriosus is now commonly performed in children. However, there are only a small number of reports of transcatheter coil embolization of adult patent ductus arteriosus (PDAs). We attempted to occlude large PDAs in 3 adult patients with Cook detachable coils and we report the usefulness and problems of such a procedure. Case Reports Case 1A 58-year-old woman had exertional dyspnea and chest discomfort. On physical examination, she had a bounding peripheral pulse and a grade 2/6 continuous murmur at the left upper sternal border. Conventional 2-dimensional echocardiography demonstrated left ventricular and atrial enlargement, and a left ventricular ejection fraction of 71%. On color Doppler echocardiography, left-to-right PDA shunt flow was visible. On transesophageal echocardiography (TEE) the minimal diameter of the PDA was 5 mm. Informed consent for coil embolization was obtained.Right-and left-heart catheterization was performed and an oxygen step-up of the blood samples was detected at the pulmonary artery level.Aortography in the left anterior oblique projection revealed a funnel-shaped PDA (type A1) with a minimal diameter being 5.2 mm (Fig 1A). Following aortography, a 0.032-inch guidewire was advanced retrogradely from the aorta through the PDA into the pulmonary artery, and another guidewire of the same size was advanced anterogradely from the pulmonary artery through the PDA into the aorta. A 6F multipurpose catheter was advanced anterogradely and the guidewire was then removed. A 5-loop coil of 8 mm in diameter was delivered successfully into the PDA. Next, when another 6-F multipurpose catheter was inserted retrogradely, the prepositioned coil was dislodged into the main pulmonary artery. The coil was then successfully retrieved by a snare. Two multipurpose catheters were once more advanced through the PDA, one retrogradely and the other anterogradely. A 5-loop coil of 8 mm in diameter was delivered into the PDA anterogradely. Without detaching the coil, another 5-loop coil of 5 mm in diameter was sequentially delivered retrogradely. Aortography revealed slight residual flow (Fig 1B). Because of the risk of coil migration and the possibility of spontaneous complete closure of the PDA, no additional coiling was attempted and the 2 coils were then detached.The next day, a slight residual shunt was observed on color Doppler echocardiography. However, the patient's exertional dyspnea and chest discomfort disappeared. During her stay in hospital, her urine was not dark colored, and blood chemistry for hemolysis was not examined. Six months after the first procedure, a hematological examination revealed severe hemolytic anemia (Table 1). Transthoracic echocardiography demonstrated a smaller left ventricle and left atrium than that of 6 months previous (Table 2). On the transthoracic and transesophageal color Doppler echocardiography, a residual left-to-right PDA shunt flow was visible. The hemolysis was thought to be due to the shunt, and the patient underwent a sec...

show abstract

Section: Discussionmentioning

confidence: 92%

Transcatheter Coil Embolization of Large-Size Patent Ductus Arteriosus in Adult Patients

et al. 1999

View full text Add to dashboard Cite

show abstract

“…Since the initial description by Portsmann et al of nonsurgical closure of PDA the percutaneous approach has become standard clinical practice 1 . Coils and devices have broadened the range of patients and anatomies treatable with percutaneous techniques [3][4][5][6] . The ADO2 device provides a solution for the closure of small to moderate-sized PDAs.…”

Section: Introductionmentioning

confidence: 99%

Early clinical experience with the new Amplatzer Ductal Occluder II for closure of the persistent arterial duct

Goonetilleke¹,

Jayarathna²,

Inthisar³

et al. 2014

Sri Lanka J Child Health

View full text Add to dashboard Cite

Objective: To describe early single-centre clinical experience with the Amplatzer Ductal Occluder II (ADO II).Method: Children with a haemodynamically significant patent ductus arteriosus (PDA) who underwent percutaneous trans-pulmonary closure with Amplatzer Ductal Occluder II (ADO2) were included. Data was collected from computer based patient records.Results: Trans-pulmonary PDA closures using ADO 2 were undertaken in 32 children (22 females) with a mean age of 1year 9 months (range 5 months to 10 years) and a mean weight of 8.2kg (range 4.2-25kg). Complete occlusion was noted pre-discharge in 31 (97%) patients. One (3%) had residual shunting after deployment followed by embolization to the left pulmonary artery on the third day of the procedure. One (3%) had mild flow acceleration in the left pulmonary artery and another (3%) had mild aortic flow obstruction following the procedure. At 7 and 30 days, echocardiography confirmed complete ductal occlusion without need for further intervention in all 31 (97%) successful cases.Conclusion: ADO II is highly effective in rapid occlusion of morphologically varied small to moderate-sized PDAs.

show abstract

“…In 1982, Kan 4 with his coauthors performed the first clinical balloon dilatation of pulmonary valve stenosis in an eight-year-old child, which ensued from Lababidi's report on successful balloon valvuloplasty for aortic stenosis. 5 In 1992, Combier 6 first reported successful closure of PDA with coils that began to be widely applied throughout the world. 7 In 1997, this occluder was greatly improved by Amplatzer, and so was born a new generation of coils named Amplatzer.…”

Section: Introductionmentioning

confidence: 99%

Clinical Efficiency and Safety Analysis of Transcatheter Interventional Therapy for Compound Congenital Cardiovascular Abnormalities

Zhang

Maoqin

et al. 2007

Clinical Cardiology

View full text Add to dashboard Cite

Objective: To investigate the efficiency and safety of transcatheter interventional therapy for compound congenital cardiovascular abnormalities. Methods: From Nov 2001 to Jun 2006, a total of 36 patients (17 male, 19 female), aged 17.20 ± 10.52, with compound congenital cardiovascular abnormalities underwent transcatheter interventional procedure. These patients included 11 with perimembranous ventricular septal defect (PVSD) and patent ductus arteriosus (PDA), 8 patients with PVSD and atrial septal defect (ASD), 8 patients with ASD and PDA, 7 patients with ASD and pulmonary stenosis (PS), 1 patient with ASD and mitral stenosis(MS), 1 patient with coarctation of aorta (COA) and PDA. According to the principle of “easy first, hard second,” balloon valvuloplasties of PS or MS were performed before the closure of PVSD, and of PDA and ASD. Electrocardiogram and transthoracic echocardiogram were examined at 4 days, 1, 2, 6 and 12 months, respectively, after each procedure. Results: Transcatheter interventional therapy for compound congenital cardiovascular abnormalities was successful in all patients. Among these, 2 occluders were planted in each of 27 patients, 7 patients with ASD combined with PS and 1 patient with ASD combined with MS underwent successfully performed balloon valvuloplasty and ASD closure, 1 patient with COA combined with PDA underwent successfully performed balloon valvuloplasty and subsequent covered stent implantation. No patient encountered serious adverse events during the (30.5 ± 14.6) months of follow‐up. Conclusions: Transcatheter interventional therapy for compound congenital cardiovascular abnormalities could obtain satisfactory results with technical feasibility. Copyright © 2007 Wiley Periodicals, Inc.

show abstract

Percutaneous closure of the small (< 2.5 mm) patent ductus arteriosus using coil embolization

Cited by 288 publications

References 8 publications

Transcatheter Coil Embolization of Large-Size Patent Ductus Arteriosus in Adult Patients

Transcatheter Coil Embolization of Large-Size Patent Ductus Arteriosus in Adult Patients

Early clinical experience with the new Amplatzer Ductal Occluder II for closure of the persistent arterial duct

Clinical Efficiency and Safety Analysis of Transcatheter Interventional Therapy for Compound Congenital Cardiovascular Abnormalities

Contact Info

Product

Resources

About